Advertisement

Mosquito-Borne Diseases

  • Jerome Goddard
Part of the Infectious Disease book series (ID)

Abstract

Mosquitoes are flies, and thus, undergo complete metamorphosis, having egg, larval, pupal, and adult stages. Larvae are commonly referred to as wigglers and pupae as tumblers. Larvae and pupae of mosquitoes are always found in water. Breeding sites maybe anything from water in discarded automobile tires to water in the axils of plants, to pools, puddles, swamps, and lakes. Mosquito species differ in their breeding habits, biting behavior, flight range, and so forth (Fig. 1). However, a generalized description of their life cycle is presented here as a basis for understanding mosquito biology and ecology. There are three subfamilies in the mosquito family (Culicidae)—Anophelinae, Culicinae, and Toxorhynchitinae. Members of the Toxorhynchitinae are huge, non-bloodsucking mosquitoes whose larvae eat mosquito larvae of other species. The larvae have a breathing tube (siphon), but it is short and conical. Most larvae in the subfamily Culicinae hang down just under the water surface by the siphon, whereas anopheline larvae lie horizontally just beneath the water surface supported by small notched organs of the thorax and clusters of float hairs along the abdomen (Fig. 2). They have no prominent siphon. Mosquito larvae feed on suspended particles in the water as well as microorganisms. They undergo four molts (each successively larger), the last of which results in the pupal stage. With optimal food and temperature, the time required for larval development can be as short as 7 d.

Keywords

Lymphatic Filariasis Yellow Fever Mosquito Vector Dengue Infection Venezuelan Equine Encephalitis Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Harwood RF and James MT. Mosquitoes. Entomology in Human and Animal Health, 7th ed. Macmillan, New York, 1979, p. 212.Google Scholar
  2. 1a.
    Bowles E. The Mosquito Book. Mississippi Department of Public Health, April 1989.Google Scholar
  3. 1b.
    USDA. ARS Technical Bulletin No. 1447, 1972.Google Scholar
  4. 2.
    Breman JG, Steketee RW. Malaria, in Public Health and Preventive Medicine, 13th ed., Last JM, Wallace RB, eds. Appleton and Lange, Norwalk, CT, 1992.Google Scholar
  5. 3.
    CDC, MMWR, vol. 39, no. 6, February 16, 1990.Google Scholar
  6. 4.
    CDC, MMWR, vol. 40, no. 6, February 15, 1991.Google Scholar
  7. 5.
    Cunnion SO, Dickens TH, Ehrhardt DA, Need JT, Wallace JG. Navy medical department guide to malaria prevention and control. Navy Environmental Health Center, Norfolk, VA, 1984.Google Scholar
  8. 6.
    Bruce-Chwatt LJ. Essential Malariology, 2nd ed., John Wiley, New York, 1985.Google Scholar
  9. 7.
    Jensen T, Dritz DA, Fritz GN, Washino RK, Reeves WC. Lake Vera revisited: parity and survival rates of Anopheles punctipennis at the site of a malaria outbreak in the Sierra Nevada foothills of California. Am J Trop Med Hyg, 1998; 59: 591–594.PubMedGoogle Scholar
  10. 7a.
    CDC. Preventing Emerging Infectious Diseases-A Strategy for the 21st Century. October, 1998.Google Scholar
  11. 8.
    Benenson AS. Control of Communicable Diseases Manual, 16th ed. American Public Health Association, 1995.Google Scholar
  12. 9.
    Goddard J. Currier M. Case histories of insect-or arachnid-caused illness. J Agromed 1995; 2: 53–61.CrossRefGoogle Scholar
  13. 9a.
    World Health Organization. WHO/VBC/89.967.Google Scholar
  14. 10.
    Goddard J. Physician’s Guide to Arthropods of Medical Importance, 2nd ed. CRC, Boca Raton, FL, 1996.Google Scholar
  15. 10a.
    Goddard J. Infections in Medicine. 1996; 13: 751.Google Scholar
  16. 11.
    Lillie TH, Schreck CE, Rahe AJ. Effectiveness of personal protection against mosquitoes in Alaska. J Med Entomol 1988; 25: 475.PubMedGoogle Scholar
  17. 12.
    Chamberlain RW. History of St. Louis encephalitis. In: Monath TP, ed. St. Louis Encephalitis. American Public Health Association, Washington, DC, 1980, p. 7.Google Scholar
  18. 13.
    Brinker KR, Monath TP. The acute disease. In: Monath TP, ed. St. Louis Encephalitis. American Public Health Association, Washington, DC, 1980, chapter 11, pp. 503–534.Google Scholar
  19. 14.
    Tsai TF, Mitchell CJ. St. Louis encephalitis. In: Monath, TP ed. The Arboviruses: Epidemiology and Ecology, vol. 4, CRC, Boca Raton, FL, 1988, chapter 42, pp. 113–143.Google Scholar
  20. 14a.
    Tsai TF, Mitchell CJ. Infections in Medicine. 1996; 13: 751.Google Scholar
  21. 15.
    National Notifiable Disease Data, Arboviruses Diseases Branch, Division of Vector-borne Infections, CDC, Ft. Collins, CO, 1998.Google Scholar
  22. 15a.
    Turrell MJ. Vector competence of three Venezuelan mosquitoes for an epizootic IC strain of Venezuelan equine encephalitis virus. J Med Entomol 1999; 36: 407–409.Google Scholar
  23. 16.
    United States Department of Agriculture, Venezuelan equine encephalomyelitis, a national emergency, USDA, APHIS-81–1, 1972.Google Scholar
  24. 17.
    Burke DS, Leake CJ. Japanese encephalitis. In Monath TP, ed. The Arboviruses: Epidemiology and Ecology, vol. 3, CRC, Boca Raton, FL, 1988, chapter 28, pp. 63–92.Google Scholar
  25. 18.
    Rappleye, WC. Epidemic encephalitis, etiology, epidemiology, treatment, Third Report, Matheson Commission, Columbia University Press, New York, 1939.Google Scholar
  26. 19.
    Gubler DJ, Clark GG, Dengue/dengue hemorrahgic fever: The emergence of a global health problem. Emerg Infect Dis 1995; 1: 55–57.PubMedCrossRefGoogle Scholar
  27. 19a.
    Gubler DJ, Clark GG, Dengue/dengue hemorrahgic fever: The emergence of a global health problem. Infections in Medicine. 1996; 13: 936.Google Scholar
  28. 20.
    CDC, MMWR, Surveillance Summary, 43/SS-2, July 22, 1994, p. 8.Google Scholar
  29. 21.
    Halstead SB, Emergence mechanisms in yellow fever and dengue. In: Scheld WM, Craig WA, Hughes JM, eds. Emerging Infections Part II, ASM, Washington, DC, 1998.Google Scholar
  30. 22.
    Cardosa MJ. Dengue vaccine design: issues and challenges. Br Med Bull 1998; 54: 395–405.PubMedCrossRefGoogle Scholar
  31. 23.
    Service MW. Mosquitoes. In: Lane RP, Crosskey RW, eds. Medical Insects and Arachnids. Chapman and Hall, London 1993: 120–240.CrossRefGoogle Scholar
  32. 24.
    Sanders EJ, Borus P, Ademba G, Kuria G, Tukei PM, LeDuc JW. Sentinel surveillance for yellow fever in Kenya. Emerg Infect Dis 1996; 2: 236–238.PubMedCrossRefGoogle Scholar
  33. 25.
    McFarland JM, Baddour LM, Nelson JE, Elkins SK, Craven RB, Cropp BC, et al. Imported yellow fever in a United States citizen. Clin Infect Dis 1997; 25: 1143–1147.PubMedCrossRefGoogle Scholar
  34. 26.
    Cope SE: Yellow fever-the scourge revealed. Wing Beats ( Florida Mosquito Control Association ), Winter 1996, pp. 14–26.Google Scholar
  35. 27.
    White M. Yellow Fever. The Commercial Appeal, Memphis Tennessee, Tuesday, October 31, 1978.Google Scholar
  36. 28.
    Bres PLJ. A century of progress in combating yellow fever. Bull WHO 1986; 64: 775–786.PubMedGoogle Scholar
  37. 29.
    Cunningham NM. Lymphatic filariasis in immigrants from developing countries. Am Fam Phys 1997; 55: 119–1204.Google Scholar
  38. 29a.
    Cunningham NM. Lymphatic filariasis in immigrants from developing countries. Infections in Medicine. 1998; 15: 608.Google Scholar
  39. 30.
    Markell EK, Voge M, John DT. Medical Parasitology, 7th ed. W.B. Saunders, Philadelphia, 1992.Google Scholar
  40. 30a.
    Markell EK, Voge M, John DT. Infections in Medicine. 1998; 15: 609Google Scholar
  41. 31.
    Brygoo ER. Epidemiology of filariasis. In: Proceedings of a Conference on Filariasis in the South Pacific, South Pacific Commission, Noumea, New Caledonia (French).Google Scholar
  42. 32.
    De Silva N, Guyatt H, Bundy, D. Anthelmintics. A comparative review of their clinical pharmacology. Drugs 1997; 53: 769–788.PubMedCrossRefGoogle Scholar
  43. 33.
    Cao WC, Van der Ploeg CP, Plaisier AP, Van der Sluijs IJ, Habbema JD. Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment. Trop Med Int Health 1997; 2: 393–403.PubMedCrossRefGoogle Scholar
  44. 34.
    Thomas JG, Sundman D, Greene JN, Coppola D, Lu L, Robinson LA, et al. A lung nodule: malignancy or the dog heartworm? Infect Med 1998; 15: 105109.Google Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Jerome Goddard
    • 1
  1. 1.Mississippi Department of HealthUniversity of Mississippi Medical CenterJacksonUSA

Personalised recommendations